Sorry, but you do not have permission to view this content.
Topic Archives:
ERIC Health Care Highlights: Member Input Needed on Legislation, Victory! Gag Clause Prohibition Compliance Attestations, Rep. Spartz on Health Care
Sorry, but you do not have permission to view this content.
ERIC Health Care Highlights: Member Ideas on PCORI Studies, Senate Finance News, Senate Judiciary Advances Drug Legislation, Commonwealth Report, and More!
Sorry, but you do not have permission to view this content.
The ERISA Industry Committee Urges Senate Judiciary Committee to Advance Legislation to Enhance Prescription Drug Competition and Affordability
WASHINGTON, February 8, 2023 – The ERISA Industry Committee (ERIC) urged members of the Senate Committee on the Judiciary in a letter to vote in favor of several bills which would improve transparency, promote competition, and prohibit practices that discourage affordability within the prescription drug market.
ERIC Urges Arkansas Legislators to Improve Access to Biosimilars Across State
Sorry, but you do not have permission to view this content.
ERIC Alert: State of the Union Highlights
Sorry, but you do not have permission to view this content.
ERIC Health Care Highlights: Telehealth Expansion For Workers Act, Proposed Rule On Contraceptive Coverage; and more!
Sorry, but you do not have permission to view this content.
The ERISA Industry Urges Congress to Pass the Telehealth Benefit Expansion for Workers Act of 2023
WASHINGTON, February 6, 2023 – The ERISA Industry Committee (ERIC) urged Congress to pass the “Telehealth Benefit Expansion for Workers Act of 2023” (H.R. 824) to allow employers to offer standalone telehealth benefits to all employees, beyond the end of the public health emergency (PHE), in particular those not enrolled in their employer’s medical plan.
ERIC Health Care Highlights: Pharmacy Benefit Manager Transparency Act; USPTO Patent Comments; And More!
Sorry, but you do not have permission to view this content.
The ERISA Industry Committee Cites Concerns with the “Pharmacy Benefit Manager Transparency Act” (S. 127)
WASHINGTON, February 2, 2023 – The ERISA Industry Committee (ERIC) today submitted a letter to Senate champions of the “Pharmacy Benefit Manager Transparency Act” (PBMTA, S. 127) outlining serious concerns with the legislation.